Proceedings: Effect of urogastrone in the Zollinger-Ellison syndrome.
D004815:Epidermal Growth Factor / Q000008:administration & dosage / Q000627:therapeutic use*; D005743:Gastrectomy; D005750:Gastric Juice / Q000032:analysis / Q000378:metabolism; D005755:Gastrins / Q000097:blood; D005768:Gastrointestinal Hormones / Q000627:therapeutic use*; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D010434:Pepsin A / Q000032:analysis; D011706:Pyloric Antrum / Q000601:surgery; D014628:Vagotomy; D015043:Zollinger-Ellison Syndrome / Q000188:drug therapy*
D005755:Gastrins; D005768:Gastrointestinal Hormones; D004815:Epidermal Growth Factor; D010434:Pepsin A